Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
983.2 INR | +1.55% | -1.44% | +42.64% |
May. 09 | Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel | MT |
May. 09 | Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5% | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.64% | 11.67B | |
+19.58% | 42.97B | |
+24.52% | 22.49B | |
+16.59% | 14.93B | |
+7.25% | 13.14B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B | |
+9.14% | 4.86B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Transcript : Zydus Lifesciences Limited, Q3 2024 Earnings Call, Feb 09, 2024